Successful treatment of urgent bleeding in von Willebrand disease with factor VIII/VWF concentrate (Humate-P®): Use of the ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapy

Joan Cox Gill, B. M. Ewenstein, A. R. Thompson, G. Mueller-Velten, B. A. Schwartz, T. Abshire, R. Ambinder, A. Angiolillo, Y. Arkel, D. Beardsley, R. Benjamin, M. Binder, F. Charbel, B. Cooper, N. Cornell, E. Czapek, P. Eisenberg, B. Ewenstein, S. Garcia-Ortiz, D. GastineauJ. Gill, G. Heggie, M. Heisel, H. Joist, C. Knupp, B. Lewis, D. Matthews, P. McKenna, S. Murukutla, J. Palascak, J. Penner, Jerry S Powell, H. Ritter, R. Francisco, A. Shapiro, T. Simpson, M. Stanek, A. R. Thompson, J. Tongol, L. Waterbury, G. White, R. Young

Research output: Contribution to journalArticlepeer-review

62 Scopus citations

Fingerprint Dive into the research topics of 'Successful treatment of urgent bleeding in von Willebrand disease with factor VIII/VWF concentrate (Humate-P®): Use of the ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences